MTE #22 Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease

Nov 09 2025
Convention Center: Room 140A, Level 1
12:45 PM - 1:30 PM
Ticketed Event

World Class Speakers

Lamia Y. Haque, MD, MPH
Discussion Leader

Lamia Y. Haque, MD, MPH

Yale School of Medicine
Margarita N German, BA, MD
Discussion Leader

Margarita N German, BA, MD

University of Wisconsin-Madison

Description

Experts provide insights into the treatment of alcohol use disorder (AUD) in patients with alcohol-associated liver disease, with a focus on cirrhosis. Topics include the efficacy of FDA-approved therapeutics and off-label use of medications for AUD, and how to manage side effects of these agents. 

Journey Maps

ALD

Objectives

  • Describe the efficacy of FDA-approved medications for alcohol use disorder.
  • Review the efficacy of off-label use of medications for alcohol use disorder.
  • Discuss strategies to manage the side-effects of medications for alcohol use disorder.